Literature DB >> 22306487

Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors.

Rashna Balsara1, Neill Li, Danielle Weber-Adrian, Louxiu Huang, Francis J Castellino.   

Abstract

Synaptic and extrasynaptic activation of the N-methyl-D-aspartate receptor (NMDAR) has distinct consequences on cell signaling and neuronal survival. Since conantokin (con)-G antagonism is NR2B-selective, which is the key subunit involved in extrasynaptic activation of the receptor, its ability to specifically elicit distinct signaling outcomes in neurons with synaptically or extrasynaptically-activated NMDARs was evaluated. Inhibition of Ca(2+) influx through extrasynaptic NMDAR ion channels was neuroprotective, as it effectively enhanced levels of activated extracellular signal-regulated kinase 1/2 (ERK1/2), activated cAMP response element binding protein (CREB), enhanced mitochondrial viability, and attenuated the actin disorganization observed by extrasynaptic activation of NMDARs. Conversely, the pro-signaling pathways stimulated by synaptically-induced Ca(2+) influx were abolished by con-G. Furthermore, subunit non-selective con-T was unable to successfully redress the impairments in neurons caused by extrasynaptically-activated NMDARs, thus indicating that NR2B-specific antagonists are beneficial for neuron survival. Neurons ablated for the NR2B subunit showed weak synaptic Ca(2+) influx, reduced sensitivity to MK-801 blockage, and diminished extrasynaptic current compared to WT and NR2A(-/-) neurons. This indicates that the NR2B subunit is an integral component of both synaptic and extrasynaptic NMDAR channels. Altogether, these data suggest that con-G specifically targets the NR2B subunit in the synaptic and extrasynaptic locations, resulting in the opposing action of con-G on differentially activated pools of NMDARs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306487      PMCID: PMC3680358          DOI: 10.1016/j.neuropharm.2012.01.018

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  68 in total

1.  Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons.

Authors:  Christopher G Thomas; Ashleigh J Miller; Gary L Westbrook
Journal:  J Neurophysiol       Date:  2005-11-30       Impact factor: 2.714

Review 2.  Survival signaling pathways activated by NMDA receptors.

Authors:  Michal Hetman; Giorgi Kharebava
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

3.  Increased ethanol resistance and consumption in Eps8 knockout mice correlates with altered actin dynamics.

Authors:  Nina Offenhäuser; Daniela Castelletti; Lisa Mapelli; Blanche Ekalle Soppo; Maria Cristina Regondi; Paola Rossi; Egidio D'Angelo; Carolina Frassoni; Alida Amadeo; Arianna Tocchetti; Benedetta Pozzi; Andrea Disanza; Douglas Guarnieri; Christer Betsholtz; Giorgio Scita; Ulrike Heberlein; Pier Paolo Di Fiore
Journal:  Cell       Date:  2006-10-06       Impact factor: 41.582

Review 4.  NMDA receptor subunits: function and pharmacology.

Authors:  Pierre Paoletti; Jacques Neyton
Journal:  Curr Opin Pharmacol       Date:  2006-11-07       Impact factor: 5.547

5.  Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death.

Authors:  Sheng-Jia Zhang; Marvin N Steijaert; David Lau; Günther Schütz; Celine Delucinge-Vivier; Patrick Descombes; Hilmar Bading
Journal:  Neuron       Date:  2007-02-15       Impact factor: 17.173

Review 6.  Glutamate-based therapeutic approaches: NR2B receptor antagonists.

Authors:  Kathleen R Gogas
Journal:  Curr Opin Pharmacol       Date:  2005-12-22       Impact factor: 5.547

Review 7.  The molecular basis of conantokin antagonism of NMDA receptor function.

Authors:  Mary Prorok; Francis J Castellino
Journal:  Curr Drug Targets       Date:  2007-05       Impact factor: 3.465

8.  Conantokins and variants derived from cone snail venom inhibit naloxone-induced withdrawal jumping in morphine-dependent mice.

Authors:  Juanjuan Wei; Mingxin Dong; Cai Xiao; Fengchao Jiang; Francis J Castellino; Mary Prorok; Qiuyun Dai
Journal:  Neurosci Lett       Date:  2006-07-20       Impact factor: 3.046

9.  Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons.

Authors:  Anton Ivanov; Christophe Pellegrino; Sylvain Rama; Iryna Dumalska; Yuriy Salyha; Yehezkel Ben-Ari; Igor Medina
Journal:  J Physiol       Date:  2006-05-01       Impact factor: 5.182

10.  NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo.

Authors:  Yitao Liu; Tak Pan Wong; Michelle Aarts; Amanda Rooyakkers; Lidong Liu; Ted Weita Lai; Dong Chuan Wu; Jie Lu; Michael Tymianski; Ann Marie Craig; Yu Tian Wang
Journal:  J Neurosci       Date:  2007-03-14       Impact factor: 6.167

View more
  3 in total

1.  Probing NMDA receptor GluN2A and GluN2B subunit expression and distribution in cortical neurons.

Authors:  Rashna D Balsara; Ashley N Ferreira; Deborah L Donahue; Francis J Castellino; Patrick L Sheets
Journal:  Neuropharmacology       Date:  2014-01-15       Impact factor: 5.250

2.  Conantokin-G attenuates detrimental effects of NMDAR hyperactivity in an ischemic rat model of stroke.

Authors:  Rashna Balsara; Alexander Dang; Deborah L Donahue; Tiffany Snow; Francis J Castellino
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

3.  Antagonist properties of Conus parius peptides on N-methyl-D-aspartate receptors and their effects on CREB signaling.

Authors:  Shailaja Kunda; John Cheriyan; Michael Hur; Rashna D Balsara; Francis J Castellino
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.